Eugenics is Back: In a range of new flavors
By Anne Rumberger and Marcy Darnovsky,
Science for the People
| 02. 29. 2024
Eugenics is widely regarded as a debunked pseudoscience—developed and promoted mostly in Nazi Germany—that fell off the political radar after the horrors of the Holocaust were revealed. In fact, twentieth century eugenics represented the mainstream science of its day and was championed by prominent figures and popular movements across the political spectrum in countries around the world. Despite widespread post-war condemnation of Nazi eugenics and striking advances in scientific understanding of genetics, eugenics never disappeared.
Today, new strains of eugenic ideas and practices are appearing in surprisingly divergent ideological, policy, and technological arenas. On the right, some wield eugenics as an accusation against liberals; others promote worldviews directly imported from the eugenic playbook. In the first category, abortion opponents and politicians claim that, in the words of Supreme Court Justice Clarence Thomas, abortion is akin to “eugenic manipulation.” In the second, white supremacists are promoting the “Great Replacement Theory,” which postulates a deliberate project by liberal elites (often under Jewish guidance) to replace white populations with more Democratic-leaning and higher birth rate non-white populations.
Eugenic ideas are also re-emerging elsewhere...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...